PAA 0.00% 17.0¢ pharmaust limited

Ann: Appendix 4C and Quarterly Update, page-110

  1. 1,656 Posts.
    lightbulb Created with Sketch. 198
    Totally understand the marketing implications that you outline NZT...
    The frustration is shared among many here.
    One needs to remember that there is significant ‘skin in the game’ by many members including the BOD.
    Although the decline is now more apparent with no new news, which is pending, upon successful news these pip fluctuations gravitating may be of insignificance to long term holders, yet significant to traders.
    The fact that we ( PAA) have sent the final report to Vet Major and have MPL in the works for further testing on COVID-19, shows company activity. The fact that this activity, as you say, can be marketed better is also true.
    The results, good-bad-ugly, will be evident by the market response.
    If there was no pending option with Vet Major nor the prospect of an anti-viral opportunity, then the current MC would reflect that too.
    Sorry about the rambling, luck all.
    As always, time will tell.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
0.000(0.00%)
Mkt cap ! $82.69M
Open High Low Value Volume
17.0¢ 17.0¢ 16.3¢ $108.2K 647.7K

Buyers (Bids)

No. Vol. Price($)
2 109170 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 117939 4
View Market Depth
Last trade - 16.10pm 17/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.